COMPANY ANNOUNCEMENT 08/2026 | INTERIM FINANCIAL REPORT Q2 2026 | PAGE 2 of 22
EXECUTIVE SUMMARY
Q2 PERFORMANCE ON TRACK – STRATEGY UPDATE SETTING DIRECTION FOR
TRANSFORMATION
Q2 2026 key highlights
• NNIT's financial performance was in line with initial expectations, despite continued customer
caution, particularly within the life science segments. However, order entry improved during the
quarter across all regions, supported by targeted growth initiatives aimed at strengthening sales
execution. Reported group revenue declined 4.5% to DKK 441.6m, corresponding to constant currency
revenue growth of -4.4%. The decline was primarily driven by the life science regions, while Public DK
and SCALES delivered solid growth contributions.
• Group EBIT excl. special items came in at DKK 21.4m in the second quarter, corresponding to a margin
of 4.8% which remained broadly stable year-over-year, reflecting the impact of cost-reduction initiatives
launched during last year, supplemented by further actions taken during this year to align capacity with
demand and streamline general and administrative expenses. In addition, Region US returned to its
strong profitability level, contributing to the sequential improvement in group margins.
• The full-year financial outlook for 2026 is maintained. Constant currency revenue growth is expected
to be single-digit negative with group EBIT margin excl. special items of 4-7% and special items being
“below last year’s level of DKK 83m”.
During the second quarter, NNIT delivered improved operational performance, reflecting the impact of
efficiency initiatives launched during the quarter and in the preceding quarter. Utilization improved significantly
and NNIT saw increased traction with customers on new project engagements, although customer hesitancy
remained pronounced among tier-1 Life Sciences customers in particular.
NNIT’s new AI frameworks (Lumina and Alera) were applied across select customer engagements, delivering
strong initial results. Early use cases demonstrate tangible efficiency gains, including material reductions in
time-to-delivery and accelerated analysis of complex legacy systems, ultimately enabling faster and better-
informed decision-making for customers. These initial results enable NNIT to become more competitive.
Beyond AI being deployed to customer projects, NNIT’s AI offering is being included in upcoming bids either as
a service or as part of the process depending on the project scope.
Moreover, Alera has been moved from launch into broader internal adaptation across NNIT. Alera is being
deployed to accelerate standardized tasks from CV search, HR-related enquires to support managers with
follow-up on ongoing activities, amongst others.
Despite the sequential performance improvements, a strategic review conducted during the quarter confirmed
that further transformative actions are required to restore sustainable, profitable growth. Accordingly, NNIT is
continuing its transformative approach by launching a program focused on optimizing, rebuilding and
reshaping commercial, delivery and operational excellence. As part of this work, NNIT will reassess its operating
model and service portfolio. The transformation program will form the foundation for a new strategic direction
leveraging NNIT’s strong existing position. NNIT will aspire to become an innovative, AI-enabled niche specialist
serving the global life sciences industry and regulated industries in Denmark.
Claus Rydkjær, President and CEO of NNIT, comments “During the second quarter, business performance
improved quarter-over-quarter, reflecting the impact of our targeted growth initiatives and cost reductions
progressing as planned. Despite the decline in revenue, profitability was broadly in line with last year.